A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.

Vered Stearns, Daniel F. Hayes, Rebecca Slack et al.|PubMed|2003

Cited by 109